Experiences and needs for work participation in employees with rheumatoid arthritis treated with anti-tumour necrosis factor therapy

被引:16
作者
Van der Meer, Marrit [1 ]
Hoving, Jan L. [1 ,2 ]
Vermeulen, Marjolein I. M. [1 ]
Herenius, Marieke M. J. [3 ]
Tak, Paul P. [3 ]
Sluiter, Judith K. [1 ]
Frings-dresen, Monique H. W. [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat Hlth, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Res Ctr Insurance Med, NL-1100 DE Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Med, Div Clin Immunol & Rheumatol, NL-1100 DE Amsterdam, Netherlands
关键词
Rheumatoid arthritis; work; participation; qualitative study; tumour necrosis factor-alpha; QUALITY-OF-LIFE; CONCOMITANT METHOTREXATE; MONOCLONAL-ANTIBODY; DISABILITY; ADALIMUMAB; MULTICENTER; PERCEPTIONS; EMPLOYMENT; CRITERIA; OUTCOMES;
D O I
10.3109/09638288.2011.582923
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Purpose. To investigate the experiences and needs with respect to work participation of employees with rheumatoid arthritis (RA) treated with anti-tumour necrosis factor (TNF) therapy. Method. Face-to-face interviews in 14 employees with RA on anti-TNF therapy focused on experiences, offered support and needs with respect to work participation. Results. Experiences regarding work participation varied and ranged from fatigue at work, having no job control, not being understood by the work environment or difficulty dealing with emotions as a result of interaction within the work environment. Support by health care professionals for work participation was considered important, especially concerning social or psychological issues. Advice in becoming aware of one's changes in abilities was highly appreciated, as was the availability of professional advice in times of an urgent work issue due to RA. Employees mentioned an increase in social support at work and job control as important facilitating factors for work participation. Conclusion. Although patients with RA report improvement in their work functioning after starting anti-TNF therapy, employees continue facing challenges in working life due to RA. For support concerning work participation, it is recommended that health care professionals are more aware of work-related problems in patients with RA treated with anti-TNF therapy.
引用
收藏
页码:2587 / 2595
页数:9
相关论文
共 37 条
  • [1] Evaluation of the effect of anti-tumor necrosis factor agent use on rheumatoid arthritis work disability: The jury is still out
    Allaire, Saralynn
    Wolfe, Frederick
    Niu, Jingbo
    Zhang, Yuqing
    Zhang, Bin
    LaValley, Michael
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (08): : 1082 - 1089
  • [2] [Anonymous], ANAL QUALITATIVE RES
  • [3] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
    ARNETT, FC
    EDWORTHY, SM
    BLOCH, DA
    MCSHANE, DJ
    FRIES, JF
    COOPER, NS
    HEALEY, LA
    KAPLAN, SR
    LIANG, MH
    LUTHRA, HS
    MEDSGER, TA
    MITCHELL, DM
    NEUSTADT, DH
    PINALS, RS
    SCHALLER, JG
    SHARP, JT
    WILDER, RL
    HUNDER, GG
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (03): : 315 - 324
  • [4] Patients with rheumatoid arthritis treated with tumour necrosis factor antagonists increase their participation in the workforce: potential for significant long-term indirect cost gains (data from a population-based registry)
    Augustsson, J.
    Neovius, M.
    Cullinane-Carli, C.
    Eksborg, S.
    van Vollenhoven, R. F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 126 - 131
  • [5] Employment and work disability in rheumatoid arthritis
    Backman, CL
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (02) : 148 - 152
  • [6] AURANOFIN THERAPY AND QUALITY-OF-LIFE IN PATIENTS WITH RHEUMATOID-ARTHRITIS - RESULTS OF A MULTICENTER TRIAL
    BOMBARDIER, C
    WARE, J
    RUSSELL, IJ
    LARSON, M
    CHALMERS, A
    READ, JL
    [J]. AMERICAN JOURNAL OF MEDICINE, 1986, 81 (04) : 565 - 578
  • [7] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    Breedveld, FC
    Weisman, MH
    Kavanaugh, AF
    Cohen, SB
    Pavelka, K
    van Vollenhoven, R
    Sharp, J
    Perez, JL
    Spencer-Green, GT
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 26 - 37
  • [8] WHICH OUTCOME MEASURES SHOULD BE USED IN RHEUMATOID-ARTHRITIS CLINICAL-TRIALS - CLINICAL AND QUALITY-OF-LIFE MEASURES RESPONSIVENESS TO TREATMENT IN A RANDOMIZED CONTROLLED TRIAL
    BUCHBINDER, R
    BOMBARDIER, C
    YEUNG, M
    TUGWELL, P
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (11): : 1568 - 1580
  • [9] Carr A, 2003, J RHEUMATOL, V30, P880
  • [10] Labour force participation among patients with rheumatoid arthritis
    Chorus, AMJ
    Miedema, HS
    Wevers, CJ
    van der Linden, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (07) : 549 - 554